IL-2-activated murine newborn liver NK cells enhance engraftment of hematopoietic stem cells in MHC-mismatched recipients

Bone Marrow Transplantation

Volumn 21, Issue 12, 1998, Pages 1245-1252

  Hirayama, M ^a   Genyea, C ^a   Brownell, A ^a   Kaplan, J ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

Engraftment; Enhancer cells; Hematopoietic stem cells; IL 2; NK cells

Indexed keywords

CD3 ANTIGEN; INTERLEUKIN 2;

ANIMAL CELL; ARTICLE; HEMATOPOIETIC STEM CELL; LIVER CELL; LYMPHOKINE ACTIVATED KILLER CELL; MOUSE; NATURAL KILLER CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031825656     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701274     Document Type: Article

References (18)

1. Azuma E, Yamamoto H, Kaplan J. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-versus-host disease. J Immunol 1989; 143: 1524-1529.
2. Nakamura H, Gress RE. Interleukin-2-enhancement of veto suppressor cell function in T cell depleted bone marrow in vitro and in vivo. Transplantation 1990; 49: 931-937.
3. Murphy WJ, Bennett M, Kumar V et al. Donor-type activated natural killer cells promote marrow engraftment and B cell development during allogeneic bone marrow transplantation. J Immunol 1992; 148: 2953-2960.
4. Kurtzberg J, Laughlin M, Graham ML et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. New Eng J Med 1996; 335: 157-166.
5. Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. New Engl J Med 1997; 337: 373-381.
6. Kaplan, J, Shope, TC, Bollinger, R, Smith J. Newborns have diminished natural killer cell activity. J Clin Immunol 1982; 2: 350-355.
7. Savary CA, Lotzova E. Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-infected bone marrow-tolerant and infant mice. J Immunol 1978; 129: 219-243.
8. Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 1961; 14: 213-222.
9. Wilcoxon F. Individual comparisons by ranking methods. Biometrics 1945; 1: 50-83.
10. Miller RG. An immunological suppressor cell inactivating cytotoxic T lymphocyte precursor cells recognizing it. Nature 1980; 287: 544-546.
11. Azuma E, Kaplan J. Role of lymphokine-activated killer (LAK) cells as mediators of veto and natural suppression. J Immunol 1988; 141: 2601-2606.
12. Gale RP. Fetal liver transplants. Bone Marrow Transplant 1992; 9 (Suppl. 1): 118-120.
13. Davenport C, Kumar V, Bennett M. Use of newborn liver cells as a murine model for cord blood cell transplantation. J Immunol 1993; 151: 1597-1605.
14. Brown MG, Scalzo AA, Matsumoto K, Yokoyama WM. The natural killer gene complex: a genetic basis for understanding natural killer cell function and innate immunity. Immunol Rev 1997; 155: 53-66.
15. d strain mice. J Immunol 1995; 155: 2911-2917.
16. Manouussaka M, Georgiou A, Rossiter B et al. Phenotypic and functional characterization of long-lived NK cell lines of different maturational status obtained from mouse fetal liver. J Immunol 1997; 158: 112-119.
17. Blazar BR, Soderling CCB, Koo GC, Vallera DA. Absence of a facilitatory role for NK1.1-positive donor cells in engraftment across a major histocompatibility barrier in mice. Transplantation 1988; 45: 876-883.
18. Kaufman CL, Colson YL, Wren SM et al. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 1994; 84: 2436-2446.